Patient Dies in Beam Trial of Sickle Cell Disease Candidate; Company Cites Conditioning.
作者信息
Philippidis Alex
机构信息
Genetic Engineering & Biotechnology News Mary Ann Liebert, Inc., publishers 140 Huguenot Street New Rochelle, NY 10801.
出版信息
Hum Gene Ther. 2024 Dec;35(23-24):951-954. doi: 10.1089/hum.2024.111924.
Abstract
摘要
相似文献
1
Patient Dies in Beam Trial of Sickle Cell Disease Candidate; Company Cites Conditioning.
Hum Gene Ther. 2024 Dec;35(23-24):951-954. doi: 10.1089/hum.2024.111924.
2
Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease.
Bone Marrow Transplant. 2000 Aug;26(4):445-9. doi: 10.1038/sj.bmt.1702518.
3
Blood and marrow transplantation for sickle cell disease: is less more?
Blood Rev. 2014 Nov;28(6):243-8. doi: 10.1016/j.blre.2014.08.001. Epub 2014 Aug 27.
4
Using fludarabine to reduce exposure to alkylating agents in children with sickle cell disease receiving busulfan, cyclophosphamide, and antithymocyte globulin transplant conditioning: results of a dose de-escalation trial.
Biol Blood Marrow Transplant. 2015 May;21(5):900-5. doi: 10.1016/j.bbmt.2015.01.015. Epub 2015 Jan 21.
5
A roaring trade? The legal trade in Panthera leo bones from Africa to East-Southeast Asia.
PLoS One. 2017 Oct 24;12(10):e0185996. doi: 10.1371/journal.pone.0185996. eCollection 2017.
6
Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease.
Semin Hematol. 2018 Apr;55(2):87-93. doi: 10.1053/j.seminhematol.2018.04.011. Epub 2018 Apr 25.
7
Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study.
Lancet Haematol. 2019 Nov;6(11):e585-e596. doi: 10.1016/S2352-3026(19)30154-1. Epub 2019 Sep 5.
8
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in children with sickle cell disease.
Br J Haematol. 2015 Jun;169(5):726-36. doi: 10.1111/bjh.13352. Epub 2015 Mar 27.
9
Unrelated Umbilical Cord Blood Transplantation for Sickle Cell Disease Following Reduced-Intensity Conditioning: Results of a Phase I Trial.
Biol Blood Marrow Transplant. 2017 Sep;23(9):1587-1592. doi: 10.1016/j.bbmt.2017.05.027. Epub 2017 May 31.
10
Genetic risk factors for cerebrovascular disease in children with sickle cell disease: design of a case-control association study and genomewide screen.
BMC Med Genet. 2003 Jul 18;4:6. doi: 10.1186/1471-2350-4-6.
引用本文的文献
1
AAV6 vectors provide superior gene transfer compared to AAV9 vectors following intramyocardial administration.
Mol Ther Methods Clin Dev. 2025 Jul 15;33(3):101532. doi: 10.1016/j.omtm.2025.101532. eCollection 2025 Sep 11.
2
CRISPR-based therapeutic genome editing for inherited blood disorders.
Nat Rev Drug Discov. 2025 Jul 14. doi: 10.1038/s41573-025-01236-y.
Zotero 插件